Insider Shareholders with Direct Ownership of Kiniksa Pharmaceuticals, Ltd. (KNSA)
This section provides a comprehensive overview of the insiders with direct ownership of Kiniksa Pharmaceuticals, Ltd. (KNSA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kiniksa Pharmaceuticals, Ltd. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Thomas W. Beetham
EVP & Chief Legal Officer |
300,000 | 2,477 | 297,523 $8.32 Million | 2 |
Feb 03, 2021
Reduced 0.83%
|
|
Sanj K Patel
CHAIRMAN & CEO |
649,382 | 557,348 | 96,674 $2.7 Million | 60 |
May 28, 2025
Reduced 39.12%
|
|
Eben Tessari
CHIEF OPERATING OFFICER |
212,000 | 257,766 | 61,563 $1.72 Million | 63 |
Jun 16, 2025
Reduced 21.94%
|
|
John F. Paolini
CHIEF MEDICAL OFFICER |
237,056 | 210,871 | 57,403 $1.6 Million | 48 |
May 07, 2025
Reduced 0.35%
|
|
Michael R Megna
CHIEF ACCOUNTING OFFICER |
137,398 | 106,435 | 32,546 $909,660 | 64 |
Jun 03, 2025
Reduced 31.85%
|
|
Mark Ragosa
CHIEF FINANCIAL OFFICER |
294,039 | 274,209 | 27,009 $754,901 | 70 |
Jun 03, 2025
Reduced 40.39%
|
| 18,474 | 0 | 18,474 $516,348 | 7 |
Jul 01, 2025
Added 5.62%
|
|
| 29,680 | 0 | 14,840 $414,778 | 1 |
Jun 06, 2019
Added 50.0%
|
|
| 12,546 | 0 | 12,546 $350,660 | 3 |
Jun 05, 2025
Added 20.19%
|
|
| 61,953 | 49,407 | 12,546 $350,660 | 11 |
Jun 11, 2025
Reduced 49.58%
|
|
| 12,546 | 0 | 12,546 $350,660 | 3 |
Jun 05, 2025
Added 20.19%
|
|
| 12,546 | 0 | 12,546 $350,660 | 3 |
Jun 05, 2025
Added 20.19%
|
|
| 12,546 | 0 | 12,546 $350,660 | 3 |
Jun 05, 2025
Added 20.19%
|
|
|
Ross Moat
CHIEF COMMERCIAL OFFICER |
229,159 | 225,030 | 9,415 $263,149 | 50 |
Jun 03, 2025
Reduced 74.56%
|
|
Qasim Rizvi
Chief Commercial Officer |
7,337 | 2,161 | 5,176 $144,669 | 2 |
Dec 31, 2020
Reduced 29.45%
|